Chemotherapy for low-grade gliomas: emerging consensus on its benefits
- PMID: 17515537
- DOI: 10.1212/01.wnl.0000266866.13748.a9
Chemotherapy for low-grade gliomas: emerging consensus on its benefits
Comment on
-
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials